Director/PDMR Shareholding
06 July 2010 - 2:35AM
UK Regulatory
TIDMGWP
RNS Number : 8539O
GW Pharmaceuticals PLC
05 July 2010
GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company")
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
Porton Down, UK, 5 July 2010: GW Pharmaceuticals (AIM: GWP) hereby provides
notification that the Company has today been notified of the following series of
share transactions, the result of which is an increase in the beneficial
interests of Dr Geoffrey Guy and Dr Stephen Wright.
The wife of Dr Stephen Wright, Research and Development Director, has today
purchased 5,000 ordinary shares of 0.1p each at the market price of 110 pence
per share. This purchase equates to 0.004% of the issued ordinary share capital.
Dr Geoffrey Guy, a Director and Executive Chairman of the Company, has today
exercised an option to acquire 120,000 ordinary shares of 0.1p each, equating to
0.09% of the issued ordinary share capital at an exercise price of 36.2 pence
per share. This follows the sale of 50,000 ordinary shares of 0.1p each on 30th
June 2010, at the market price of 124 pence; 30,000 ordinary shares of 0.1p each
on 2nd July 2010 at the market price of 109.6 pence and the sale of 38,678
ordinary shares of 0.1p each today at the market price of 109 pence per share.
The total number of shares sold of 118,678 equates to 0.09% of the issued
ordinary share capital.
Following these notifications Dr Guy's beneficial interest has increased to
18,345,274 ordinary shares, amounting to 14.11% of the shares in issue, and Dr
Wright's beneficial interest has increased to 5,000 ordinary shares, amounting
to 0.004% of the shares in issue.
The total number of shares outstanding in the Company is 130,041,372 ordinary
shares of 0.1p each.
For further information, please contact:
GW Pharmaceuticals PLC +44
(0)1980 557 000
Adam George, Company Secretary
Piper Jaffray Ltd (Nominated Adviser)
Neil Mackison/Rupert Winckler +44 (0)
203 142 8700
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLLFVRDSIEIII
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about GW Pharm. (London Stock Exchange): 0 recent articles
More Gw Pharmaceuticals News Articles